Research Summary
Tranexamic Acid Cut Blood Loss and Transfusions in Knee Replacement Without Raising Clot Risk, Review of 17 Trials Finds
A drug called tranexamic acid (TXA) reduced bleeding and the need for blood transfusions during total knee replacement, and it did not appear to raise the risk of blood clots in the legs. That is the conclusion of a systematic review and meta-analysis from researchers in Henan, China, published in BMC Surgery.
What was studied
Knee replacement surgery can cause significant blood loss, and some patients need a transfusion afterward. TXA helps blood clot by slowing the breakdown of clots, and it is widely used in joint replacement. Because it works on clotting, people often ask whether it could raise the risk of deep vein thrombosis (DVT), a clot in a deep leg vein.
The researchers searched PubMed, Embase, Web of Science and the Cochrane Library for randomized controlled trials comparing TXA with a control in primary, one-sided total knee replacement. They combined the results of 17 studies.
Key findings
- Blood loss: TXA reduced blood loss by an average of about 423 mL compared with control.
- Transfusions: TXA lowered the risk of needing a transfusion (risk ratio 0.55), meaning roughly 45% lower risk, and results were consistent across studies.
- Blood clots: There was no significant difference in DVT rates between TXA and control groups.
What it means for people with knee pain
If you are planning a knee replacement, this review supports what many surgical teams already do: using TXA to limit bleeding and reduce the chance you will need donated blood, without a detected increase in leg clots. Whether TXA is right for you depends on your own health history, such as past clots or heart problems, so ask your surgeon and anesthesia team.
Limitations
Results for blood loss varied widely between studies, likely because of differences in doses, timing and how blood loss was measured. The authors also found signs that small studies may have exaggerated the transfusion benefit. The review covered only one-sided primary knee replacements, and the abstract does not compare specific doses or routes (IV versus applied in the joint).
Frequently asked questions
- What is tranexamic acid used for in knee replacement?
- Tranexamic acid (TXA) is a medicine that slows the breakdown of blood clots. In knee replacement it is used to reduce bleeding. In this review of 17 trials it cut blood loss by about 423 mL on average and lowered transfusion risk.
- Does tranexamic acid increase the risk of blood clots after knee surgery?
- In the randomized trials pooled in this review, there was no significant difference in deep vein thrombosis between patients who got TXA and those who did not. People with a history of clots should still discuss it with their surgeon.
- Will I need a blood transfusion after knee replacement?
- Many patients do not. In this review, TXA lowered the risk of needing a transfusion by roughly 45% compared with no TXA. Your own risk depends on your health and the surgery.
Sudden severe pain, swelling, or can't bear weight? Seek medical care promptly. In an emergency call 911.